Table 7 Whole blood (A), renal function (B), biochemical results (C) and hepatic function (D) of the patients who took BCc1 nanomedicine revealed that none of the patients suffered deficiency
Index | Unit | Amount |
|---|---|---|
(A) Whole blood function | ||
WBC | ×1000/mm3 | 5.1 ± 1.3 |
RBC | Mill/mm3 | 4.4 ± 0.6 |
HGB | g/dl | 12.5 ± 1.8 |
HCT | % | 40.1 ± 4.5 |
MCV | Fl | 88.4 ± 10.2 |
MCH | pg | 28.8 ± 4.3 |
MCHC | g/dl | 32.9 ± 1.8 |
Platelet | ×1000/mm3 | 195 ± 27 |
RDW |  | 43 ± 21.1 |
PDW | Fl | 13.3 ± 0.8 |
MPV | Fl | 10 ± 1.6 |
(B) Renal function | ||
Urea | mg/dl | 30.4 ± 13.6 |
Creatinine | mg/dl | 1.0 ± 0.1 |
(C) Biochemical function | ||
Iron | µg/dl | 56 ± 15 |
TIBC | µg/dl | 314 ± 30 |
UIBC | µg/dl | 258 ± 10 |
Ferritin | ng/dl | 250 ± 80 |
Sodium | mmol/l | 139 ± 7 |
Potassium | mmol/l | 4.1 ± 0.7 |
Chloride | mmol/l | 105 ± 10 |
(D) Hepatic function | ||
Triglycerides | mg/dl | 102 ± 48 |
Total cholesterol | mg/dl | 183 ± 22 |
AST (SGOT) | U/l | 19.1 ± 5.1 |
ALT (SGPT) | U/l | 14.3 ± 4.3 |
Alkaline phosphatase | IU/l | 286.6 ± 95 |
Bilirubin (total) | mg/dl | 0.725 ± 0.09 |
Bilirubin (direct) | mg/dl | 0.2 ± 0.1 |